Your browser doesn't support javascript.
loading
A mathematical simulation model to determine the optimal endoscopic screening strategy for detection of H. pylori-naïve gastric neoplasms.
Ishibashi, Fumiaki; Okusa, Kosuke; Tokai, Yoshitaka; Hirasawa, Toshiaki; Kawakami, Tomohiro; Mochida, Kentaro; Yanai, Yuka; Yokoi, Chizu; Hayashi, Yuko; Ozawa, Shun-Ichiro; Uraushihara, Koji; Minato, Yohei; Nakanishi, Hiroyuki; Ueyama, Hiroya; Kataoka, Mikinori; Toyama, Yuzo; Mizokami, Yuji; Suzuki, Sho.
Afiliação
  • Ishibashi F; Department of Gastroenterology, International University of Health and Welfare Ichikawa Hospital, 6-1-14, Konodai, Ichikawa-shi, Chiba, 272-0827, Japan. ishibashi-gast@iuhw.ac.jp.
  • Okusa K; Faculty of Science and Engineering, Department of Data Science for Business Innovation, Chuo University, Tokyo, 112-8551, Japan.
  • Tokai Y; Department of Gastroenterology, Cancer Institute Hospital, Tokyo, 135-8550, Japan.
  • Hirasawa T; Department of Gastroenterology, Cancer Institute Hospital, Tokyo, 135-8550, Japan.
  • Kawakami T; Koganei Tsurukame Clinic, Endoscopy Center, Tokyo, 184-0004, Japan.
  • Mochida K; Department of Gastroenterology, International University of Health and Welfare Ichikawa Hospital, 6-1-14, Konodai, Ichikawa-shi, Chiba, 272-0827, Japan.
  • Yanai Y; Koganei Tsurukame Clinic, Endoscopy Center, Tokyo, 184-0004, Japan.
  • Yokoi C; National Center for Global Health and Medicine, Department of Gastroenterology, Tokyo, 162-8655, Japan.
  • Hayashi Y; National Center for Global Health and Medicine, Department of Gastroenterology, Tokyo, 162-8655, Japan.
  • Ozawa SI; National Center for Global Health and Medicine, Department of Medical Examination Center, Tokyo, 162-8655, Japan.
  • Uraushihara K; Department of Gastroenterology and Hepatology, Japan Community Health Care Organization Yamanashi Hospital, Yamanashi, 400-0025, Japan.
  • Minato Y; Department of Gastroenterology, Showa General Hospital, Tokyo, 187-8510, Japan.
  • Nakanishi H; Department of Gastrointestinal Endoscopy, NTT Medical Center Tokyo, Tokyo, 141-8625, Japan.
  • Ueyama H; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, 180-8610, Japan.
  • Kataoka M; Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, 113-8431, Japan.
  • Toyama Y; Department of Gastroenterology, International University of Health and Welfare Mita Hospital, Tokyo, 108-8239, Japan.
  • Mizokami Y; Department of Gastroenterology, New Tokyo Hospital, Chiba, 270-2232, Japan.
  • Suzuki S; Department of Medical Examination Center, New Tokyo Hospital, Chiba, 270-2232, Japan.
Gastric Cancer ; 2024 Jun 27.
Article em En | MEDLINE | ID: mdl-38937306
ABSTRACT

BACKGROUND:

The effectiveness of esophagogastroduodenoscopy (EGD) screening in cohorts with low Helicobacter pylori prevalence is unknown. This study aimed to develop an optimally efficient EGD screening strategy for detecting H. pylori-naïve gastric neoplasms (HpNGNs).

METHODS:

EGD data of 12 institutions from 2016 to 2022 were retrospectively analyzed. Age-related HpNGN prevalence, tumor growth rate, missing rate, and detection threshold size were calculated from the databases. Subsequently, using clinical data, a novel mathematical model that simultaneously simulated demographic changes and HpNGN detection was developed. Screening strategies using different starting ages (40/45/50 years) and intervals (2/5/10 years) were also compared. The detection rates of all tumors occurring within the virtual cohort and number-needed-to-test (NNT) were measured as outcomes.

RESULTS:

Data of 519,368 EGDs and 97 HpNGNs (34 pure signet ring cell carcinomas, 26 gastric adenocarcinomas of the fundic gland type, 30 foveolar gastric adenoma-Raspberry type, and seven undifferentiated-type cancer cases) were analyzed. A virtual cohort with a 70-year time horizon was used to simulate the occurrence, growth, and detection of 346,5836 people. Among the strategies with detection rate > 50%, the screening strategy with a 5-year interval starting at 45 years of age had the lowest NNT. Adopting this strategy, most HpNGNs were detected at < 20 mm in size, and the deep submucosal invasion rate was less than 30%.

CONCLUSIONS:

A mathematical simulation model revealed that screening every 5 years starting at 45 years of age could efficiently assist in identifying HpNGNs at an early stage.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article